Insights That
Move You Forward
Helping you make smarter decisions, avoid costly missteps, and
bring safe, effective products to market with confidence
Trying to Keep Up in May
May’s Trying to Keep Up episodes covered AI diagnostics, RAPID, FDA leadership changes, PCCPs, real-world evidence, cybersecurity, and the evolving future of MedTech regulation—plus the month’s best terrible jokes.
What Happens After Clinical Trial Close-Out: Transitioning to Reimbursement
Clinical trial close-out is no longer the end of the development process. In 2026, sponsors must transition quickly from regulatory evidence generation to reimbursement and market access planning. Learn how clinical strategy, real-world evidence, payer expectations, and post-market planning now shape commercialization success for medical devices and combination products.
Trying to Keep Up in April
April’s Trying to Keep Up episodes covered FDA shifts, clinical strategy decisions, and the realities of working in MedTech right now. This recap breaks down the key takeaways, what they mean for your team, and includes a full roundup of the podcast’s now-signature intro jokes.
Navigating the FDA During a Government Shutdown
When the U.S. government shuts down, FDA operations slow—and medical device companies can face costly delays. In this Global Medical Device Podcast Q&A, NMCG President and former FDA Scientific Reviewer Michael Nilo explains what continues, what stops, and how MedTech leaders can strategically navigate the disruption.